Literature DB >> 10323331

The role of stress in the regulation of drug metabolizing enzymes in mice.

M Konstandi1, M Marselos, A M Radon-Camus, E Johnson, M A Lang.   

Abstract

The role of stress in the regulation of several enzymatic systems which are involved in the biotransformation of xenobiotics in the liver was investigated in this study using restraint stress as a stress model. The results demonstrated that stress suppressed total basal P450 content (35%) and basal ethoxyresorufin 7-dealkylase (EROD) activity (33%), while slightly increasing basal methoxyresorufin 7-dealkylase (MROD) activity (20%). Basal pentoxyresorufin 7- dealkylase (PROD) and coumarin 7-hydroxylase (COH) activities were not affected. On the other hand, restraint stress increased total P450 content in 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene (TCPOBOP)-treated mice (35%), while slightly suppressing PROD activity (26%). In addition, CYP2E1 dependent p-nitrophenol hydroxylation (PNP), was suppressed (40%) by stress in TCPOBOP-treated animals and cytosolic aldehyde dehydrogenases were not affected. Although stress had no effect on basal P4502A5 activity, the inducibility of this hepatic activity increased 2-fold after stress exposure. A pronounced suppression (7-fold) in glutathione content was observed in lungs of TCPOBOP treated mice after stress, whereas basal levels remained unaffected. In addition, only a slight suppression (20%) in liver glutathione content was found in both treatment groups. Northern blot analysis revealed that restraint stress had a relatively suppressive effect on control CYP1A2 expression in the liver. In contrast, stress markedly enhanced the expression of liver CYP2A5 in TCPOBOP-treated mice, but did so to a lesser extent in controls. Stress also increased CYP2A5 mRNA in TCPOBOP-treated mice to a greater degree than the activity of the corresponding cytochrome. On the other hand, liver P4502A5 activity was found to be induced by TCPOBOP by about 2.5-fold. However, the drug does not appear to be involved in the expression of CYP2A5. Finally, although the activity of liver P4502A5 cytochrome was found to be increased 3, 8 and 27 h after stress, after which it gradually declined up to 75 h, CYP2A5 liver expression appeared to be suppressed 3, 8, 27 and 51 h after stress, while 75 h later it apparently reached normal levels. In conclusion, the results of this study showed that restraint stress significantly alters several enzymatic systems differently at a basal level than under conditions of TCPOBOP induction. In addition, stress was found to significantly interfere with the expression processes of CYP1A2 and CYP2A5.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10323331     DOI: 10.1007/BF03189999

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  29 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

3.  Distinct induction profiles of three phenobarbital-responsive mouse liver cytochrome P450 isozymes.

Authors:  P Honkakoski; S Auriola; M A Lang
Journal:  Biochem Pharmacol       Date:  1992-05-28       Impact factor: 5.858

4.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

5.  Stress-induced alterations in microsomal drug metabolism in the adrenalectomized rat.

Authors:  R L Furner; R E Stitzel
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

6.  Colorimetric determination of acetaldehyde in the presence of formaldehyde.

Authors:  D Dagani; M C Archer
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

Review 7.  Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury.

Authors:  U A Boelsterli
Journal:  Drug Metab Rev       Date:  1993       Impact factor: 4.518

8.  Genetic evidence for many unique liver microsomal P-450-mediated monooxygenase activities in heterogeneic stock mice.

Authors:  M A Lang; J E Gielen; D W Nebert
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

Review 9.  Cytochrome P450: progress and predictions.

Authors:  M J Coon; X X Ding; S J Pernecky; A D Vaz
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

10.  Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.

Authors:  P V Nerurkar; S S Park; P E Thomas; R W Nims; R A Lubet
Journal:  Biochem Pharmacol       Date:  1993-09-01       Impact factor: 5.858

View more
  4 in total

Review 1.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

2.  Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling.

Authors:  Catherine S Lane; Yuqin Wang; Richard Betts; William J Griffiths; Laurence H Patterson
Journal:  Mol Cell Proteomics       Date:  2007-02-11       Impact factor: 5.911

3.  Dopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver.

Authors:  P Harkitis; E P Daskalopoulos; F Malliou; M A Lang; M Marselos; A Fotopoulos; G Albucharali; M Konstandi
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

4.  Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy.

Authors:  Maria Konstandi; Elizabeth O Johnson; Matti A Lang
Journal:  Front Neurosci       Date:  2022-03-23       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.